Clinical trials
Molecular Imaging clinical trials
Below are recruiting molecular imaging clinical trials, each written for real people, not researchers. We’re tracking 50 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07119294Recruiting
FAPI PET/MR imaging for glioblastoma
This study uses a special PET/MR scan to look at certain cells called cancer-associated fibroblasts in glioblastoma brain tumors. It aims to see if this imaging approach can better detect tumors or their recurrence, helping guide treatment decisions.
BrusselsAges 18 years+ - NCT07276789RecruitingPhase 2
Single-dose dye imaging for lung cancer surgery
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07294638Recruiting
New imaging method to find cancer spread in early gastric cancer
This trial tests a new dye that helps surgeons see if early gastric cancer has spread to nearby lymph nodes. It might help guide the extent of surgery needed.
Guangzhou, GuangdongAges 18 years+ - NCT07301827Recruiting
New PET imaging for kidney cancer diagnosis
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Wuhan, HubeiAges 18 years+ - NCT02641145Recruiting
PET/MRI scans in light-chain amyloid heart disease
This study uses special PET and heart MRI scans to better understand light-chain amyloidosis affecting the heart. The scans may help researchers see how the disease behaves in different patient groups and treatment states.
Boston, MassachusettsAges 18–99 - NCT03207464RecruitingPhase 1/Phase 2
PET/MRI scan study for nerve inflammation in multiple sclerosis
This early-phase study uses a special PET scan and an MRI to look at nerve-related inflammation in people with multiple sclerosis (MS). The goal is to see whether this scan can detect MS-related changes, which could improve how MS is studied in the future.
Boston, MassachusettsAges 18–60 - NCT07419178Recruiting
New scan test for scarring in blood cancers
This study tests a new way to detect scar tissue in the bone marrow using a special scan and blood test. It might help doctors see how your disease is changing without needing a bone marrow biopsy.
Parma, ItalyAges 18 years+ - NCT07548099Recruiting
PET scan study of aorta inflammation in aneurysm patients
This research uses a special imaging scan (PET/CT) to take detailed pictures of inflammation in the aorta (the main blood vessel from your heart). Researchers want to understand why some people develop bulges in their aorta called aneurysms. If you have an aneurysm or are a healthy volunteer, this study may help improve how doctors detect and treat this condition.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06516237Recruiting
New imaging for fibrosis in ulcerative colitis
This study looks at new ways to detect scarring (fibrosis) in the bowel using advanced imaging and tests. It may help doctors better understand and monitor ulcerative colitis. If you are already having a colonoscopy, you may be able to join.
Milan, LombardyAges 18 years+ - NCT06731842Enrolling by invitation
Brain scans and blood tests for Alzheimer's disease
This study uses a special brain scan (PET imaging) and blood tests to look for early signs of Alzheimer's and other brain diseases. It aims to improve how we detect and understand these conditions.
StockholmAges 30–85 - NCT05828628Recruiting
Study tests imaging and tissue markers in brain lymphoma
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
SuttonAges 18 years+ - NCT04944940Recruiting
Study tests blood, scans, and genes in SBMA and healthy men
This study looks for early “biomarkers” (measurable signs) in the body using blood tests, imaging scans, and sometimes other procedures in men with genetically confirmed spinal and bulbar muscular atrophy (SBMA). The results may help future drug studies by showing better ways to track disease changes over time.
Bethesda, MarylandAges 18–120 - NCT06058650Recruiting
Using molecular breast imaging to guide breast biopsies
This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.
Rochester, MinnesotaAges 18 years+ - NCT06466018Recruiting
Eye disorder biomarkers study for European adults
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
ParisAges 18 years+ - NCT06468332Recruiting
AI learning from MRI and tissue to improve prostate cancer care
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
NovaraAges 18–80 - NCT06584123Recruiting
Molecular imaging of pituitary adenoma with 18F-FET PET
This study uses a special PET scan (18F-FET) to get clearer images of pituitary adenomas (non-cancerous growths at the base of the brain). It is for people who have already had one type of PET scan and can help doctors understand the tumor better without invasive procedures.
Cambridge, CambridgeshireAges 18–100 - NCT02804269Recruiting
Ages 16 to 90 for heart disease information collection
This is a repository program that collects health and imaging-related information to better understand heart (cardiovascular) health and disease. You may be able to join if you are in the age range and share your data for research use.
Singapore, SingaporeAges 16–90 - NCT02605785Recruiting
Imaging study to track tau protein in PSP
This study uses brain imaging to look at a protein called tau in people with progressive supranuclear palsy (PSP). It aims to better understand the disease and how tau changes over time, which may help future treatments.
Rochester, MinnesotaAges 35 years+ - NCT03054792Enrolling by invitationPhase 1
MRI test to map low-oxygen areas in childhood sarcomas
This Phase 1 study uses special MRI scans to look at “low-oxygen” parts of a childhood sarcoma. It aims to help doctors better understand the tumor before standard treatment that may include chemotherapy and sometimes radiation.
Toronto, OntarioAges 6–18 - NCT02740634Recruiting
Brain imaging study for Alzheimer's disease
This study uses brain scans to understand Alzheimer's disease and related conditions that affect memory, language, or vision. It looks at how changes in the brain happen over time in people with these diagnoses.
Rochester, MinnesotaAges 21–80 - NCT04713722Recruiting
Study of early stress and depression using brain imaging
This study looks at how early life stress may be linked to depression, using brain scans. You’ll be asked about your history and asked to do brain imaging to help researchers understand these brain and mood changes.
Belmont, MassachusettsAges 20–32 - NCT05518617Recruiting
Imaging study for inherited Parkinson’s using PET, SPECT, and spinal fluid
This trial tests how well special brain scans (PET/SPECT) and spinal fluid tests can show changes in people with inherited (genetic) Parkinson’s. It may help researchers understand what’s happening in the brain and improve how these conditions are measured.
Exeter, DevonAges 25–80 - NCT06015802Recruiting
Predicting pituitary tumor behavior with markers and scans
This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.
Guangzhou, GuangdongAges 18–70 - NCT06908291Recruiting
Photoacoustic imaging test for breast nodules and chemo response
This study uses a new imaging technique that combines light and sound to examine breast lumps. It may help doctors diagnose breast cancer, determine its type, and see how well chemotherapy is working.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Molecular Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for molecular imaging?
- Yes. Clin2 currently lists 50 recruiting molecular imaging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a molecular imaging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a molecular imaging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.